Exciting news in the tech and insurance industries as Slide successfully raises a whopping $175,000,000 in funding! Slide is revolutionizing the insurance landscape with its advanced technology, utilizing artificial intelligence and Big Data to provide tailored insurance solutions to today's consumers. This substantial funding will further empower Slide in enhancing its platform, allowing for even greater customization and efficiency in the insurance selection process. With this investment, Slide is poised to continue its mission of simplifying insurance choices for individuals, ensuring they receive the right coverage that fits their specific needs and budget. Congratulations to Slide on this remarkable achievement, leading the way in making insurance more accessible and personalized for all.
Insurtech Innovator: Slide Secures $175M in Funding to Revolutionize Insurance Industry
Recently funded 路 $175.0MInsurance
Get the full Slide company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
